Corteva, Inc. $CTVA Shares Purchased by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd raised its position in Corteva, Inc. (NYSE:CTVA) by 6.9% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 153,829 shares of the company’s stock after acquiring an additional 9,891 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Corteva were worth $10,403,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Corteva during the second quarter valued at approximately $434,220,000. Pacer Advisors Inc. increased its position in shares of Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock worth $165,164,000 after purchasing an additional 2,382,715 shares in the last quarter. Amundi increased its position in shares of Corteva by 125.3% during the third quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after purchasing an additional 1,899,248 shares in the last quarter. Marshall Wace LLP raised its stake in Corteva by 1,365.9% in the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock valued at $134,882,000 after purchasing an additional 1,686,309 shares during the last quarter. Finally, Squarepoint Ops LLC lifted its holdings in Corteva by 423.6% in the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after purchasing an additional 1,406,199 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.14% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. BNP Paribas Exane boosted their price target on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Royal Bank Of Canada upped their price objective on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Finally, Argus upgraded shares of Corteva to a “strong-buy” rating in a report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Stock Down 0.9%

Shares of CTVA opened at $77.34 on Friday. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a fifty day simple moving average of $75.10 and a two-hundred day simple moving average of $69.40. The company has a market capitalization of $52.01 billion, a PE ratio of 48.95, a price-to-earnings-growth ratio of 2.67 and a beta of 0.72.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter in the previous year, the company posted $0.32 EPS. The company’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s payout ratio is presently 45.57%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.